Dr. Vinay Prasad's Views on Key ASCO Breast Cancer Trials
Dr. Vinay Prasad is now Director of FDA's CBER Division, Review his thoughts on NATALEE, DESTINY-Breast04, and postMONARCH breast cancer clinical trials
LUNAR Trial: Did Emory Get Caught in the Hype?
Novocure's LUNAR Trial presented at ASCO23 led to a dramatic drop in the stock price of NVCR. Following ASCO23, Emory University continued to praise the LUNAR s…